Keynote 55 Pembrolizumab for Heavily Pre-Treated Patients

Share:

Listens: 0

GRACEcast ALL Subjects audio and video

Science


6th video in our series ASCO 2016 Head and Neck Roundtable, featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD. Dr. Weiss moderates the discussion regarding keynote 55: Pembrolizumab for heavily pre-treated patients.